logologo
QuantliQuantli

Arcutis Biotherapeutics Inc

ARQT

NASDAQ

Biotechnology

$26.19

USD

+0.36 (+1.39%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $3.25B

Volume 1.1M

Price Target

$40.00$40.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $40.00 and a min estimate of $40.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$40.00

+$5.0 vs prior

Implied Upside

+52.7%

+19.1% vs prior

Analyst Covering

1

-4 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

17%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Serge Belanger

Needham

Buy

Maintained

1 week ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

GRAL

Grail Inc

$67.87

-0.5%

IOVA

Iovance Biotherapeutics Inc

$6.98

+7.1%

NRIX

Nurix Therapeutics Inc

$27.05

-0.5%

CLDX

Celldex Therapeutics Inc

$41.95

-1.6%

VCYT

Veracyte Inc

$41.25

-3.2%

IMNM

Immunome Inc

$27.20

+3.0%

IDYA

IDEAYA Biosciences Inc

$36.30

-1.0%

IRON

Disc Medicine Inc

$78.84

-1.5%